Fluorescent peptide biosensor for probing the relative abundance of cyclin-dependent kinases in living cells

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Kurzawa, Laetitia ^a   Pellerano, Morgan ^a   Coppolani, J B ^a   Morris, May C ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL EXTRACT; CYCLIN DEPENDENT KINASE; CYCLINE; FLUORESCENT PEPTIDE; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG; FLUORESCENT DYE; PEPTIDE;

ARTICLE; BINDING AFFINITY; BIOSENSOR; CANCER DIAGNOSIS; CELL SCREENING; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; PROCESS OPTIMIZATION; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN EXPRESSION; AMINO ACID SEQUENCE; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; GENETIC PROCEDURES; HELA CELL; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; PROTEIN CONFORMATION; PROTEIN TRANSPORT;

AMINO ACID SEQUENCE; BIOSENSING TECHNIQUES; CELL SURVIVAL; CYCLIN-DEPENDENT KINASES; CYCLINS; FLUORESCENT DYES; HELA CELLS; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN CONFORMATION; PROTEIN TRANSPORT;

EID: 80054767002     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026555     Document Type: Article

References (42)

1. Malumbres M, Barbacid M, (2005) Mammalian cyclin-dependent kinases. Trends Biochem Sci 30: 630-641.
2. Obaya AJ, Sedivy JM, (2002) Regulation of cyclin-Cdk activity in mammalian cells. Cell Mol Life Sci 59: 126-142.
3. Satyanarayana A, Kaldis P, (2009) Mammalian cell cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms. Oncogene 28: 2925-2939.
4. Merrick KA, Fisher RP, (2010) Putting one step before the other: distinct activation pathways for Cdk1 and Cdk2 bring order to the mammalian cell cycle. Cell Cycle 9: 706-714.
5. Jeffrey PD, Russo AA, Polyak K, Gibbs E, Hurwitz J, et al. (1995) Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature 376: 313-320.
6. Morgan DO, (1997) Cyclin-dependent kinases: Engines, Clocks, and Microprocessors. Annu Rev Cell Dev Biol 13: 261-291.
7. Morris MC, Gondeau C, Tainer JA, Divita G, (2002) Kinetic Mechanism of Activation of the Cdk2/Cyclin A complex. J Biol Chem 277: 23847-23853.
8. Lolli G, (2010) Structural dissection of cyclin dependent kinases regulation and protein recognition properties. Cell Cycle 9: 1551-1561.
9. Malumbres M, Sotillo R, Santamaria D, Galan J, Cerezo A, et al. (2004) Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. Cell 118: 493-504.
10. Santamaria D, Barrière C, Cerqueira A, Hunt S, Tardy C, et al. (2007) Cdk1 is sufficient to drive the mammalian cell cycle. Nature 448: 811-815.
11. Lapenna S, Giordano A, (2009) Cell cycle kinases as therapeutic targets for cancer. Nat Rev Drug Discovery 8: 547-566.
12. Malumbres M, Barbacid M, (2009) Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 9: 153-166.
13. Malumbres M, Barbacid M, (2001) To cycle or not to cycle: a critical devision in cancer. Nat Rev Cancer 1: 222-231.
14. Malumbres M, Barbacid M, (2007) Cell cycle kinases in cancer. Curr Opin Genetics and Development 17: 60-65.
15. Harwell RM, Mull BB, Porter DC, Keyomarsi K, (2004) Activation of cyclin-dependent kinase 2 by full length and low molecular weight forms of cyclin E in breast cancer cells. J Biol Chem 279: 12695-12705.
16. Ekberg J, Holm C, Jalili S, Richter J, et al. (2005) Expression of cyclin A1 and cell cycle proteins in hematopoietic cells and acute myeloid leukaemia and links to patient outcome. Eur J Haematol 75: 106-115.
17. Husdal A, Bukholm G, Bukholm IR, (2006) The prognostic value and overexpression of cyclin A is correlated with gene amplification of both cyclin A and cyclin E in breast cancer patients. Cell Oncol 18: 107-116.
18. Suzuki T, Urano T, Miki Y, Moriya T, et al. (2007) Nuclear cyclin B1 in human breast carcinoma as a potent prognostic factor. Cancer Sci 98: 644-651.
19. Kim JK, Diehl JA, (2009) Nuclear cyclin D1: an oncogenic driver in human cancer. J Cell Physiol 220: 292-296.
20. Ionov Y, (2010) A high throughput method for identifying personalized tumor-associated antigens. Oncotarget 1: 148-155.
21. Holmes JK, Solomon MJ, (1996) A predictive scale for evaluating cyclin dependent kinase substrates. J Biol Chem 271: 25240-25246.
22. Schulman BA, Lindstrom DL, Harlow E, (1998) Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A. Proc Natl Acad Sci U S A 95: 10453-10458.
23. Brown N, Noble EM, Endicott JA, Johnson LN, (1999) The structural basis for specificity and recruitment peptides for cyclin-dependent kinases. Nat Cell Biol 1: 438-443.
24. Lowe ED, Tews I, Cheng KY, Brown NR, Gul S, et al. (2002) Specificity determinants of recruitment peptides bound to phospho-CDK2/cyclin A. Biochemistry 41: 15625-15634.
25. Loving GS, Sainlos M, Imperiali B, (2010) Monitoring protein interactions and dynamics with solvatochromic fluorophores. Trends in Biotechnology 28: 73-83.
26. Brown NR, Lowe ED, Petri E, Skamnaki V, Antrobus R, et al. (2007) Cyclin B and cyclin A confer different substrate recognition properties on CDK2. Cell Cycle 6: 1350-1359.
27. Kurzawa L, Pellerano M, Morris MC, (2010) PEP and CADY-mediated Delivery of Fluorescent Peptides and Proteins into Living Cells. Biochim Biophys Acta 1798: 2274-2285.
28. Itzhaki JE, Gilbert CS, Porter AC, (1997) Construction by gene targeting in human cells of a «conditional» CDC2 mutant that rereplicates its DNA. Nat Genet 15: 258-265.
29. Hahn AT, Jones JT, Meyer T, (2009) Quantitative analysis of cell cycle phase durations and PC12 differentiation using fluorescent biosensors. Cell Cycle 8: 1044-1052.
30. Kurzawa K, Morris MC, (2010) Cell Cycle Markers and Biosensors. Chembiochem 11: 1037-1047.
31. Wang H, Nakata E, Hamachi I, (2009) Recent progress in strategies for the creation of protein-based fluorescent biosensors. Chembiochem 10: 2560-2577.
32. Morris MC, (2010) Fluorescent Biosensors of Intracellular Targets: from genetically-encoded reporters to modular polypeptide probes. Cell Biochemistry and Biophysics 56: 19-37.
33. Riedl J, Crevenna AH, Kessenbrock K, Yu JH, Neukirchen D, et al. (2008) LifeAct: a versatile marker to visualize F-actin. Nat.Methods 5: 605-607.
34. Nalbant P, Hodgson L, Kraynov V, Toutchkine A, Hahn KM, (2004) Activation of endogenous Cdc42 visualized in living cells. Science 10: 1615-1619.
35. Sharma V, Wang Q, Lawrence DS, (2008) Peptide-based fluorescent sensors of protein kinase activity: design and applications. Biochimica et Biophysica Acta 1784: 94-99.
36. Lukovic E, Vogel Taylor E, Imperiali B, (2009) Monitoring protein kinases in cellular media with highly selective chimeric reporters. Angew Chem Int Ed Engl 48: 6828-6831.
37. Jiang T, Olson ES, Nguyen QT, Roy M, Jennings PA, et al. (2004) Tumor imaging by means of proteolytic activation of cell-penetrating peptides. Proc Natl Acad Sci U S A 101: 17867-17872.
38. Heitz F, Morris MC, Divita G, (2009) Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics. Br J Pharmacol 157: 195-206.
39. Morris MC, Gros E, Aldrian-Herrada G, Choob M, Archdeacon J, et al. (2007) A non-covalent peptide-based carrier for in vivo delivery of DNA mimics. Nucleic Acids Res 35 (7): e49.
40. Crombez L, Morris MC, Dufort S, Aldrian-Herrada G, Nguyen Q, et al. (2009) Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth. Nucleic Acids Res 37: 4559-4569.
41. Heitz F, Morris MC, Fesquet D, Cavadore JC, Dorée M, et al. (1997) Interactions of cyclins with cyclin-dependent kinases: a common interactive mechanism. Biochemistry 36: 4995-5003.
42. Crombez L, Aldrian-Herrada G, Konate K, Nguyen QN, McMaster GK, et al. (2009) A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells. Mol Ther 17: 95-103.